Prognosis

Pfizer’s Covid Shot Is Approved for Young Children in Canada

Pfizer-BioNTech Covid-19 pediatric vaccinePhotographer: Hannah Beier/Bloomberg
Lock
This article is for subscribers only.

Canadian health authorities authorized Pfizer Inc.’s Covid-19 shot for children age 5 to 11, opening the door for a new phase of the country’s vaccination drive.

Health Canada on Friday announced it has approved a lower dose of Pfizer Inc. and BioNTech SE‘s Covid-19 vaccine for all school-age children.